No abstract available
MeSH terms
-
Anaplastic Lymphoma Kinase
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Carboplatin / administration & dosage
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / genetics*
-
Carcinoma, Squamous Cell / drug therapy
-
Carcinoma, Squamous Cell / genetics
-
Cell Cycle Proteins / genetics*
-
Cisplatin / administration & dosage
-
ErbB Receptors / genetics*
-
Gene Fusion / genetics*
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / genetics*
-
Microtubule-Associated Proteins / genetics*
-
Molecular Targeted Therapy*
-
Mutation
-
Precision Medicine* / trends
-
Protein-Tyrosine Kinases / genetics
-
Proto-Oncogene Proteins / genetics
-
Proto-Oncogene Proteins c-ret / genetics
-
Receptor Protein-Tyrosine Kinases / genetics*
-
Serine Endopeptidases / genetics*
Substances
-
Cell Cycle Proteins
-
Microtubule-Associated Proteins
-
Proto-Oncogene Proteins
-
Carboplatin
-
Anaplastic Lymphoma Kinase
-
EGFR protein, human
-
ErbB Receptors
-
Protein-Tyrosine Kinases
-
Proto-Oncogene Proteins c-ret
-
RET protein, human
-
ROS1 protein, human
-
Receptor Protein-Tyrosine Kinases
-
EML4 protein, human
-
Serine Endopeptidases
-
Cisplatin